About Target RWE
Target RWE is a Healthcare company based in Durham (United States) founded in 2017, and was acquired by Highlander Health in January 2025. Marketing services to the pharmaceutical industry are provided. The company has 116 employees. Target RWE has completed 1 acquisition, including NoviSci. Target RWE offers products and services including causalRisk™, Data Curation Engine, and causalPHR™. Its focus areas include Biopharma Outsourcing, Consulting, Business and Market Access & HEOR. Its legal entity is TARGET PHARMASOLUTIONS, INC. Its competitors include Secura Bio, STATinMED Research and Hylant; 1 of its 3 listed competitors has raised funding.
Company details
Target RWE was established in 2017 in Durham, United States. Operations center on delivering marketing services within the pharmaceutical sector. Support is offered to clients through targeted strategies and data-driven approaches tailored to healthcare needs. The company functions primarily in the United States, focusing on industry-specific marketing solutions that address regulatory and market challenges in pharmaceuticals. Expertise is applied to enhance client outreach and compliance.
- Headquarters Durham, United States
- Employees 116
- Stage Acquired
- SectorsHealthcare
- Website targetrwe.com
- Social LinkedIn X
- Acquired by Highlander Health (Jan 2025)
- Legal Name Target Pharmasolutions, Inc
- Investors
- Employee Count116
- Investments & Acquisitions
- Acquired byHighlander Health
(Jan 2025)
Products & Services of Target RWE
Target RWE offers a comprehensive portfolio of products and services, including causalRisk™, Data Curation Engine, and causalPHR™.
Software for causal inference in real-world data analysis
Processes complex healthcare data using AI and machine learning
Visualizes patient journeys and disease progression data
Investors in Target RWE
Target RWE has secured backing from 1 investor. Prominent investors backing the company include Highlander Health.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Advances healthcare research through platforms and invests in innovative personalized care technologies. | 2024 | highlanderhealth.com | Dallas, United States |
Investor details for Target RWE
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Target RWE
13 people are tracked at Target RWE (8 in leadership, 4 in board & advisors, 1 in team); the tracked headcount is 116.
| Name | Role | Group |
|---|---|---|
Michael W. Fried | Co-Founder & Chief Medical Officer | Leadership |
Joy Peter | VP, Evidence Solutions | Leadership |
Tara Bridgeman | Senior Director, Human Resources | Leadership |
Julie Mallory Crawford | VP, RWE & Strategic Partnerships | Leadership |
Matt Roth | VP, Finance | Leadership |
Alan Brookhart | Chief Scientific Officer | Leadership |
Rob Sullivan | Chief Data & Analytics Officer | Leadership |
Nathan Nussbaum | Head Of Data Innovation | Leadership |
Meg Powell | Co-Founder & Chair | Board & advisors |
Eric Edell | Board Member | Board & advisors |
Andrew Von Eschenbach | Senior Advisor | Board & advisors |
Franz Humer | Senior Advisor | Board & advisors |
Sonia Li | Board Observer | Team |
Complete people profiles for Target RWE
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Target RWE
Target RWE has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include NoviSci.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Provider of an online scientific sourcing tool for researchers and professionals | novisci.com | Durham, United States | 2016 | Jan 2021 | •••• |
Complete acquisition details for Target RWE
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Target RWE
3 dated milestones of Target RWE across 8 years, from founding to its latest funding, stage changes and deals.
- Founded Target RWE is founded.
- Acquisition Acquires NoviSci.
- Exit Acquired by Highlander Health.
Competitors of Target RWE
Target RWE has 3 listed competitors in our database, 1 of them funded. They include Secura Bio, STATinMED Research and Hylant.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| securabio.com | 2018 | Henderson, United States | $55M | Consulting services for market access and health outcomes are provided. | ||
| statinmed.com | 2007 | Ann Arbor, United States | Healthcare data analytics services provider | |||
| hylant.com | 1935 | Toledo, United States | 849 | Offers business insurance, employee benefits, and risk consulting services worldwide. |
Detailed competitors of Target RWE
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Target RWE
The website of Target RWE (targetrwe.com) receives about 7.4K visits a month.
- Monthly visits7.4K
▼ 11.8% vs previous month
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Target RWE (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Target Rwe
Complete news archive for Target RWE
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Target RWE
Target RWE was founded in 2017.
Target RWE is headquartered in Durham, United States. It is registered at Durham, North Carolina, United States.
Target RWE has 116 employees.
Target RWE was established in 2017 in Durham, United States. Operations center on delivering marketing services within the pharmaceutical sector. Support is offered to clients through targeted strategies and data-driven approaches tailored to healthcare needs. The company functions primarily in the United States, focusing on industry-specific marketing solutions that address regulatory and market challenges in pharmaceuticals. Expertise is applied to enhance client outreach and compliance.
Target RWE's top competitors include STATinMED Research, Secura Bio and Hylant.
Target RWE offers causalRisk™, Data Curation Engine, and causalPHR™.
Target RWE has made 1 acquisition, including NoviSci.
Target RWE has 1 investor. Key investors include Highlander Health.
Target RWE operates through Target Pharmasolutions, Inc.
Yes. Target RWE was acquired by Highlander Health in January 2025.